Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Cumming, US

Dale Cumming, Acton, MA US

Patent application numberDescriptionPublished
20080280327Novel P-Selectin Ligand Protein - A novel P-selectin ligand glycoprotein is disclosed, comprising the amino acid sequence set forth in SEQ ID NO:2 or by the amino acid sequence set forth in SEQ ID NO:4. DNA sequences encoding the P-selectin ligand protein are also disclosed, along with vectors, host cells, and methods of making the P-selectin ligand protein. Pharmaceutical compositions containing the P-selectin ligand protein and methods of treating inflammatory disease states characterized by P-selectin- and E-selectin-mediated intercellular adhesion are also disclosed.11-13-2008
20090028883Novel P-selectin Ligand Protein - A novel P-selectin ligand glycoprotein is disclosed, comprising the amino acid sequence set forth in SEQ ID NO:2 or by the amino acid sequence set forth in SEQ ID NO:4. DNA sequences encoding the P-selectin ligand protein are also disclosed, along with vectors, host cells, and methods of making the P-selectin ligand protein. Pharmaceutical compositions containing the P-selectin ligand protein and methods of treating inflammatory disease states characterized by P-selectin- and E-selectin-mediated intercellular adhesion are also disclosed.01-29-2009
20090104180NOVEL P-SELECTIN LIGAND PROTEIN - A novel P-selectin ligand glycoprotein is disclosed, comprising the amino acid sequence set forth in SEQ ID NO:2 or by the amino acid sequence set forth in SEQ ID NO:4. DNA sequences encoding the P-selectin ligand protein are also disclosed, along with vectors, host cells, and methods of making the P-selectin ligand protein. Pharmaceutical compositions containing the P-selectin ligand protein and methods of treating inflammatory disease states characterized by P-selectin- and E-selectin-mediated intercellular adhesion are also disclosed.04-23-2009

Patent applications by Dale Cumming, Acton, MA US

Dale Anthony Cumming, Acton, MA US

Patent application numberDescriptionPublished
20100162417METHODS FOR INCREASING THE DIVERSITY OF MONOCLONAL ANTIBODIES PRODUCED AGAINST AN ANTIGEN - The present invention relates to methods for increasing the diversity of monoclonal antibodies produced against an antigen. The methods of the invention utilize immunization of a murine host defective in one or more enzymes involved in a post-translational modification of a polypeptide or a modification of a lipid, wherein said modification is exposed on a cell surface. The invention also relates to monoclonal antibodies produced by these methods and which are not produced when a normal mouse is immunized with the same antigen. The invention further relates to compositions comprising these monoclonal antibodies, as well as to such monoclonal antibodies bound or conjugated to a toxin, a detectable marker or to a solid support.06-24-2010

David Cumming, Park City, UT US

Patent application numberDescriptionPublished
20080249890ANONYMOUS ONLINE MATCHING FOR PRODUCTS AND SERVICES - The present invention extends to methods, systems, and computer program products for anonymous online matching for products and services. A listing party uploads a detailed profile (e.g., indicating goods and/or service they desire to purchase) to a matching system. The matching system, automatically and/or manually, detects a match with a potential seller. The matching system sends a redacted profile to the potential seller. The redacted profile includes product and/or service information but omits indentify information of the listing party. The seller determines if further investigation is worthwhile (e.g., purchase of the detailed profile including identify information) based on the content of the redacted profile.10-09-2008

David E. Cumming, Park City, UT US

Patent application numberDescriptionPublished
20090063308METHODS AND SYSTEMS FOR ENCOURAGING REDUCTIONS IN POLLUTANT GAS PRODUCTION - The methods and systems described herein encourage reductions in the production of pollutant gases by converting the individual's local efforts into a demonstration of the individual's global impact. The systems and methods enable an individual to establish a network of associated individuals. The efforts of the individuals within the network are then associated in a way that enables the individuals to see the results of their own efforts and the results of others they have influenced. Individuals in the network may be associated in a hierarchical-type structure, similar to a family-tree type structure, and some or all of the carbon savings of descendants may be attributed to the parent, grandparent, etc. Any of a variety of computational methods may be applied to reward an individual for efforts to encourage others to reduce the production of pollutant gases.03-05-2009

Duncan G. Cumming, Rancho Palos Verdes, CA US

Patent application numberDescriptionPublished
20130127174Method for Generating Tidal Energy Utilizing the Scalar Gravitational Potential of Celestial Bodies - Tidal energy generator uses the scalar gravitational potential to utilize energy from celestial bodies. Kinetic energy is extracted from the celestial objects by means of a system including a rotatable arm, a mass fluctuation producing system arranged on the arm and including dielectric material whose mass fluctuates when subjected to a changing electromagnetic field in view of the scalar gravitational potential of the celestial objects, a rotation system that rotates the arm at a variable speed to cause rotation of the mass fluctuation producing system thereon, and a control system that controls the mass fluctuation producing system and rotation system in order to accelerate the dielectric material when it has a relatively light mass and decelerate the dielectric material when it has a relatively heavy mass. Excess energy arising from an energy differential between the acceleration and deceleration of the dielectric material is directed to a load.05-23-2013

James Stuart Cumming, Laguna Beach, CA US

Patent application numberDescriptionPublished
20110313519Accommodating Intraocular Lens - An intraocular lens for insertion into a capsular bag of an eye comprises: an optic; and at least one plate haptic coupled to the optic by one or more flexible connecting members. The plate haptic with flexible finger extensions is designed to engage the periphery of the capsular bag. An increase in radial pressure upon constriction of the ciliary muscle causes the rigid posteriorly vaulted plate haptics to move centrally to further increase the vitreous cavity pressure with constriction of the ciliary muscle: the optic with its thin stretchable hinge across the connecting member is then displaced anteriorly along the axis of the eye. The haptic includes a longitudinally rigid frame to restrict deformation of the haptic in a longitudinal direction while permitting deformation in a transverse direction. Furthermore, the flexible connecting members include one or more hinged straps that extend radially and/or longitudinally from the optic. The optic can move forwards and backwards, relative to both the distal and proximal ends of the plate haptics, in response to ciliary muscle contraction and relaxation with an increase and decrease of vitreous cavity pressure. Finger-like projection extends from the plate haptic to engage the capsular bag to center and fixate the accommodating lens within the capsular bag.12-22-2011
20110313524Vitreous Compressing Plate Haptic - A plate haptic is used with an intraocular lens optic displaceable in response to vitreous pressure changes. The plate haptic comprises: a plurality of opposing lateral portions; a distal portion having a plurality of opposing projections extending substantially laterally therefrom; and a proximal portion comprising a strap across which is a hinge connecting the lens optic to the haptic. The intersection of the proximal portion with each lateral portion forms a plurality of appendages, or paddles, to partially surround the optic. The appendages, projections, and hinged straps combine to substantially aid displacement of the lens optic in response to changes in vitreous pressure.12-22-2011
20110313525Tilt Stabilizing Accommodating Intraocular Lens - An intraocular lens for insertion into a capsular bag of an eye. A plurality of flexible connecting members couples a lens optic to a pair of opposing of plate haptics. The coupling members stabilize the optic with respect to the haptics. The coupling members are spaced apart straps having grooves that increase lens response to changes in vitreous pressure.12-22-2011
20110313526Semi-Rigid Framework For A Plate Haptic Accommodating Intraocular Lens - A plate haptic for an accommodating intraocular lens. The plate haptic has a haptic body that is substantially rigid in a longitudinal direction and substantially flexible in a transverse direction. A chassis is integral to the haptic body. The chassis causes the haptic body to be substantially more rigid in a longitudinal direction than in a transverse direction.12-22-2011
20120296425Variable Focus Intraocular Lens - A variable focus intraocular lens comprises an optic coupled to at least one haptic at a flexion that sets a non-zero angle between the optic and the haptic.11-22-2012
20120310344Biased accommodating intraocular lens - An accommodating intraocular lens has a lens optic that is coupled to at least one haptic and is anteriorly biased with respect thereto.12-06-2012

Jared N. Cumming, Garwood, NJ US

Patent application numberDescriptionPublished
20080200445Heterocyclic aspartyl protease inhibitors - Disclosed are compounds of the formula I 08-21-2008
20090258868HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I10-15-2009
20090306047HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I12-10-2009
20090312341CYCLIC AMINE BACE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT - Disclosed are novel compounds of the formula12-17-2009
20100152138CYCLIC AMINE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT - Disclosed are compounds of the formula06-17-2010
20100292203HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I11-18-2010
20110218194HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I09-08-2011
20120148603PENTAFLUOROSULFUR IMINO HETEROCYCLIC COMPOUNDS AS BACE-1 INHIBITORS, COMPOSITIONS, AND THEIR USE - In its many embodiments, the present invention provides provides certain pentafluorosulfur imino heterocyclic compounds, including compounds Formula (I): and tautomers thereof, and solvates, prodrugs, esters, and deuterates of said compounds and said tautomers, and pharmaceutically acceptable salts of said compounds, tautomers, solvates, prodrugs, esters, and deuterates, wherein each of R06-14-2012
20120183563IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE - In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): (I) and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R07-19-2012
20120189642IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE - In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (a) and include tautomers, solvates, prodrugs, esters, and deuterates thereof, and pharmaceutically acceptable salts of said compounds, tautomers, solvates, prodrugs, esters, and deuterates, wherein each of R07-26-2012
20120195881PENTAFLUOROSULFUR IMINO HETEROCYCLIC COMPOUNDS AS BACE-1 INHIBITORS, COMPOSITIONS AND THEIR USE - In its many embodiments, the present invention provides certain pentafluorosulfur imino heterocyclic compounds, including compounds Formula (a) and pharmaceutically acceptable salts thereof. Compounds of Formula (a) have the general structure: (a) wherein each variable is selected independently and as defined herein. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimers Disease, are also disclosed.08-02-2012
20120231017HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I09-13-2012
20120231018HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I09-13-2012
20120232064ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of formula I09-13-2012
20120276118HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I11-01-2012
20130018066HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I01-17-2013

Patent applications by Jared N. Cumming, Garwood, NJ US

Jared N. Cumming, Kenilworth, NJ US

Patent application numberDescriptionPublished
20110110957PHENYL-SUBSTITUTED 2-IMINO-3-METHYL PYRROLO PYRIMIDINONE COMPOUNDS AS BACE-1 INHIBITORS, COMPOSITIONS, AND THEIR USE - In its many embodiments, the present invention provides certain 2-imino-3-methyl pyrrolo pyrimidone compounds, including compounds Formula (II): and include tautomers, steroisomers, or pharmaceutically acceptable salts or solvates of said compounds, stereoisomers, or said tautomers, wherein R05-12-2011

Michelle Cumming, Pacific Grove, CA US

Patent application numberDescriptionPublished
20090299259Head trauma cap bandage and method - An emergency head trauma cap bandage and method of use, which, when applied, applies compression pressure to stop bleeding, doesn't compromise cervical spine immobilization, doesn't come apart during treatment and transport, and doesn't require a caregiver to re-wrap the dressing.12-03-2009
20100016775Head trauma bandage and method - An emergency head trauma bandage and method of use, which, when applied, applies minimal pressure to stop bleeding, doesn't compromise cervical spine immobilization, allows for fast and effective application of ice/cold packs to control intracranial/internal swelling, doesn't come apart during treatment and transport, and doesn't require a caregiver to re-wrap the dressing.01-21-2010
20100331752Helmet trauma bandage and method - An emergency helmet trauma bandage and method of use, which, when applied, applies minimal pressure to stop bleeding, doesn't compromise cervical spine immobilization, allows for fast and effective application of ice/cold packs to control intracranial/internal swelling, doesn't come apart during treatment and transport, and doesn't require a caregiver to re-wrap the dressing.12-30-2010
20120296252Head Trauma Bandage Cap and Method - An emergency head trauma bandage cap with a detachable strap system and method of use, which, when applied to the head, delivers minimal pressure to control bleeding, doesn't compromise cervical spine immobilization, allows for fast and effective application of cold packs to control intracranial/internal swelling or hot packs to prevent hypothermia in non-trauma situations, doesn't come apart during treatment and transport, and doesn't require a caregiver to re-wrap the dressing.11-22-2012

Patent applications by Michelle Cumming, Pacific Grove, CA US

Robert Cumming, Williamsburg, VA US

Patent application numberDescriptionPublished
20090173697METHOD AND APPARATUS FOR THE PRODUCTION AND DELIVERY OF MONOCHLORAMINE INTO WATER STREAMS - Monochloramine is efficiently manufactured by introducing controlled quantities of an ammonia source and a chlorine source in a small side-stream of water in a small diameter pipe under turbulent flow conditions. The ammonia source and chlorine source can be injected in either order and are separated by a sufficient distance to ensure that the first chemical is adequately diffused throughout the water prior to the injection of the second chemical. A sufficient length of a mixing chamber insures that turbulent flow is maintained for a length of time sufficient to thoroughly mix the two chemicals to produce monochloramine. This mixing technique allows for the manufacture of high concentrations of monochloramine at atmospheric pressure without off gassing.07-09-2009

Sarah Cumming, Plymouth, MN US

Patent application numberDescriptionPublished
20080234660Steerable Catheter Using Flat Pull Wires and Method of Making Same - A catheter assembly includes an inner liner made of flexible material and an outer layer having a steering mechanism. The steering mechanism includes at least one flat wire and a corresponding lumen through which the flat wire may travel. The steering mechanism may also include at least one pull ring to which the flat wires are attached. A layer of heat shrink material may encompass the outer layer. A braided wire assembly, which may have a braid density that varies along the length of the catheter, may also be provided in the outer layer. The overall cross-section of the catheter assembly is preferably substantially circular. A catheter shaft may include a plurality of segments of differing hardness characteristics. The outer layer typically comprises a melt processing polymer such that the catheter assembly may be laminated using heat. 09-25-2008
20090024110CATHETER AND INTRODUCER CATHETER HAVING TORQUE TRANSFER LAYER AND METHOD OF MANUFACTURE - The instant invention relates generally to catheters and to introducer catheters used to help deliver catheters or other medical devices to locations within the human body. In particular, the instant invention relates to large diameter catheters and introducer catheters having a torque transfer layer that includes at least two flat wires braided into a wire mesh. The flat wires have a width of at least about 0.007 inches and a depth of at least about 0.003 inches. The lumen diameter of the catheter is at least about 6 French. The torque transfer layer provides increased strength, flexibility, and kink resistance.01-22-2009
20100314031Steerable Catheter Using Flat Pull Wires and Having Torque Transfer Layer Made of Braided Flat Wires - A catheter assembly includes an inner liner made of flexible material and an outer layer having a steering mechanism. The steering mechanism includes at least one flat wire and a corresponding lumen through which the flat wire may travel. The steering mechanism may also include at least one pull ring to which the flat wires are attached. A layer of heat shrink material may encompass the outer layer. A braided wire assembly may also be provided in the outer layer, and may be formed by braiding a plurality of flat wires into a wire mesh. The overall cross-section of the catheter assembly is preferably substantially circular. A catheter shaft may include a plurality of segments of differing hardness characteristics. The outer layer typically comprises a melt processing polymer such that the catheter assembly may be laminated using heat.12-16-2010
20110154640CATHETER AND INTRODUCER CATHETER HAVING TORQUE TRANSFER LAYER AND METHOD OF MANUFACTURE - The instant invention relates generally to catheters and to introducer catheters used to help deliver catheters or other medical devices to locations within the human body. In particular, the instant invention relates to large diameter catheters and introducer catheters having a torque transfer layer that includes at least two flat wires braided into a wire mesh. The flat wires have a width of at least about 0.007 inches and a depth of at least about 0.003 inches. The lumen diameter of the catheter is at least about 6 French. The torque transfer layer provides increased strength, flexibility, and kink resistance.06-30-2011

Patent applications by Sarah Cumming, Plymouth, MN US

Sarah E. Cumming, Plymouth, MN US

Patent application numberDescriptionPublished
20120029504SYSTEM AND METHOD FOR PRESENTING INFORMATION REPRESENTATIVE OF LESION FORMATION IN TISSUE DURING AN ABLATION PROCEDURE - A method and system for presenting information representative of lesion formation is provided. The system comprises an electronic control unit (ECU). The ECU is configured to acquire a value for an ablation description parameter and/or a position signal metric, wherein the value corresponds to a location in the tissue. The ECU is further configured to evaluate the value, assign it a visual indicator of a visualization scheme associated with the parameter/metric corresponding to the value, and generate a marker comprising the visual indicator such that the marker is indicative of the acquired value. The method comprises acquiring a value for the parameter/metric, and evaluating the value. The method further includes assigning a visual indicator of a visualization scheme associated with the parameter/metric corresponding to the value, and generating a marker comprising the visual indicator.02-02-2012